↓ Skip to main content

Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases

Overview of attention for article published in BMC Infectious Diseases, March 2006
Altmetric Badge

Citations

dimensions_citation
109 Dimensions

Readers on

mendeley
54 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases
Published in
BMC Infectious Diseases, March 2006
DOI 10.1186/1471-2334-6-66
Pubmed ID
Authors

Alexander M Aiken, Philip C Hill, Annette Fox, Keith PWJ McAdam, Dolly Jackson-Sillah, Moses D Lugos, Simon A Donkor, Richard A Adegbola, Roger H Brookes

Abstract

New tools are required to improve tuberculosis (TB) diagnosis and treatment, including enhanced ability to compare new treatment strategies. The ELISPOT assay uses Mycobacterium tuberculosis-specific antigens to produce a precise quantitative readout of the immune response to pathogen. We hypothesized that TB patients in The Gambia would have reduced ELISPOT counts after successful treatment.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Belgium 1 2%
Unknown 52 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 30%
Student > Ph. D. Student 8 15%
Student > Master 7 13%
Other 3 6%
Student > Doctoral Student 3 6%
Other 11 20%
Unknown 6 11%
Readers by discipline Count As %
Medicine and Dentistry 24 44%
Agricultural and Biological Sciences 12 22%
Immunology and Microbiology 6 11%
Biochemistry, Genetics and Molecular Biology 2 4%
Nursing and Health Professions 2 4%
Other 3 6%
Unknown 5 9%